Site içinde arama yapın

Subodh Adke bir ses eklendi Networking
2026-05-05 11:46:01 -

(R)-N-Boc-3-(Aminomethyl)Pyrrolidine Market 2026–2034: Chiral Pharmaceutical Intermediates Driving CNS, Oncology, and Antiviral Drug Development
(R)-N-Boc-3-(Aminomethyl)Pyrrolidine market was valued at USD 28.4 million in 2025 and is projected to reach USD 58.2 million by 2034, exhibiting a remarkable CAGR of 7.4% during the forecast period. (R)-N-Boc-3-(Aminomethyl)Pyrrolidine is a specialized chiral pyrrolidine derivative featuring a tert-butoxycarbonyl (Boc) protecting group and an aminomethyl substituent at the 3-position....

0 Yorumlar 0 hisse senetleri 671 Views 0 önizleme

Please log in to like, share and comment!
Accrete Pharma bir ses eklendi Health
2026-10-15 08:31:18 -

Accrete Pharmaceuticals Private Limited – Bulk Drug Intermediates and Oncology Products
Accrete Pharmaceuticals Private Limited is a company based in India that works with medicines that fight cancer and with materials used to make those medicines, including Imatinib Intermediate. The company focuses on making sure that everything it produces is of quality and that it knows a lot about the products it sells. It also likes to make sure that customers are happy. The company helps...

0 Yorumlar 0 hisse senetleri 17 Views 0 önizleme

Please log in to like, share and comment!